Efectos de la infección in vitro de células monocítico-macrofágicas por Chlamydia y su relación con los valores de lípidos

Takahashi, 1996, Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells, Cardiovasc Res, 32, 422, 10.1016/0008-6363(96)00085-5 Ross, 1999, Atherosclerosis-an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Ross, 1996, The pathogenesis of atherosclerosis, 1, 441 Watanabe, 1996, Inflammatory and immunological nature of atherosclerosis, Int J Cardiol, 54, 51, 10.1016/S0167-5273(96)88773-0 Cook, 1996, Infectious agents and atherosclerotic vascular disease, Q J Med, 89, 727, 10.1093/qjmed/89.10.727 Epstein, 1996, The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus, Lancet, 348, 13, 10.1016/S0140-6736(96)98005-8 Vallance, 1997, Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link?, Lancet, 349, 1391, 10.1016/S0140-6736(96)09424-X Leinonen, 1993, Pathogenic mechanisms and epidemiology of Chlamydia pneumoniae, Eur Heart J, 14, 57 Lopez-Virella, 1994, Interactions between bacterial lipopolysacharides and serum lipoproteins and their possible role in coronary heart disease, Eur Heart J, 14, 118 Sung, 1996, Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease, Heart, 76, 305, 10.1136/hrt.76.4.305 Danesh, 1997, Chronic infections and coronary heart disease: Is there a link?, Lancet, 350, 430, 10.1016/S0140-6736(97)03079-1 Kaukoranta-Tolvanen, 1996, Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of cytokine response, Microb Pathog, 2, 215, 10.1006/mpat.1996.0056 Ellis, 1997, Infection and coronary heart disease, J Med Microbiol, 46, 535, 10.1099/00222615-46-7-535 Alvarez, 1986, Lipids, lipoproteins, and apoproteins in serum during infection, Clin Chem, 32, 142, 10.1093/clinchem/32.1.142 Jackson, 1997, Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. Evaluation of the innocent gystander hypothesis, Am J Pathol, 150, 1785 Ramirez, 1996, Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia Pneumoniae/Atherosclerosis Study Group, Ann Intern Med, 125, 979, 10.7326/0003-4819-125-12-199612150-00008 Saikku, 1988, Serological evidence of an association of a novel Chamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet, 2, 983, 10.1016/S0140-6736(88)90741-6 Melnick, 1994, Cytomegalovirus DNA in arterial wall of patient with atherosclerosis, J Med Virol, 42, 170, 10.1002/jmv.1890420213 Danesh, 1998, Risk factors for coronary heart disease and infection with Helicobacter pylori: Meta-analysis of 18 studies, BMJ, 316, 1130, 10.1136/bmj.316.7138.1130 Tsuchiya, 1980, Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int J Cancer, 26, 171, 10.1002/ijc.2910260208 Boyum, 1968, Separation of leukocytes from blood and bone marrow, Scand J Clin Lab Invest, 21, 7 Hunt, 1978, Separation of lymphocite subpopulations, 24, 13 Black, 1991, Antigenic variation among strains of Chlamydia pneumoniae, J Clin Microbiol, 29, 1312, 10.1128/JCM.29.7.1312-1316.1991 Fan, 1996, Glucocorticoids modulate taxol cytotoxicity in human solid tumor cells, Cell Pharmacol, 3, 343 Collins, 1997, Major DNA fragmentation is a late event in apoptosis, J Histochem Cytochem, 45, 923, 10.1177/002215549704500702 Grayston, 1990, A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR, J Infect Dis, 161, 618, 10.1093/infdis/161.4.618 Saikku, 1992, Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study, Ann Intern Med, 116, 273, 10.7326/0003-4819-116-4-273 Cook, 1995, Chlamydia pneumoniae and acute arterial thrombotic disease, Circulation, 92, 3148 Fagerberg, 1999, Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: A prospective study in middle-age to elderly men with treated hypertension, Stroke, 30, 299, 10.1161/01.STR.30.2.299 Strachan, 1999, Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study, BMJ, 318, 1035, 10.1136/bmj.318.7190.1035 Miettinen, 1996, Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland, Eur Heart J, 17, 682, 10.1093/oxfordjournals.eurheartj.a014934 Ridker, 1999, Prospective study of Chlamydia pneumoniae IgG seropositivity and risks on future myocardial infarction, Circulation, 99, 1161, 10.1161/01.CIR.99.9.1161 Nieto, 1999, Chlamydia pneumoniae infection and incident coronary heart disease. The Risk in Communities Study, Am J Epidemiol, 150, 149, 10.1093/oxfordjournals.aje.a009974 Romeo, 2000, Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis, Clin Cardiol, 23, 327, 10.1002/clc.4960230504 Muhlestein, 1998, Bacterial infectious and atherosclerosis, J Invest Med, 45, 396 Shor, 1992, Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atherosclerotic plaques, S Afr Med J, 82, 158 Muhlestein, 1996, Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease, J Am Coll Cardiol, 27, 1555, 10.1016/0735-1097(96)00055-1 Juvonen, 1997, Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms, J Vasc Surg, 25, 499, 10.1016/S0741-5214(97)70260-X Ouchi, 1998, Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases, J Med Microbiol, 47, 907, 10.1099/00222615-47-10-907 Fong, 1997, Rabbit model for Chlamydia pneumoniae infection, Clin Microbiol, 35, 48, 10.1128/JCM.35.1.48-52.1997 Laitinen, 1997, Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits, Infects Immun, 65, 4832, 10.1128/IAI.65.11.4832-4835.1997 Muhlestein, 1998, Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model, Circulation, 97, 633, 10.1161/01.CIR.97.7.633 Moazed, 1997, Murine models of Chlamydia pneumoniae infection and atherosclerosis, J Infect Dis, 175, 883, 10.1086/513986 Hu, 1999, The atherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae, J Clin Invest, 103, 747, 10.1172/JCI4582 Saikku, 1998, Animal models for Chlamydia pneumoniae infection, Atherosclerosis, 140, 517 Gupta, 1997, Elevated Chlamydia pneumoniae antibodies cardiovascular events and azithromycin in male survivors of myocardial infarction, Circulation, 96, 404, 10.1161/01.CIR.96.2.404 Gurfinkel, 1997, Randomized trial of roxithomycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group, Lancet, 350, 404, 10.1016/S0140-6736(97)07201-2 Gurfinkel, 1999, Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study, Eur Heart J, 20, 121, 10.1053/euhj.1998.1283 Anderson, 1999, Circulation, 99, 1540, 10.1161/01.CIR.99.12.1540 Kalmam, 1999, Comparative genomes of Chlamydia pneumoniae and Chlamydia trachomatis, Nat Genet, 21, 385, 10.1038/7716 Gaydos, 1996, Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells, Infect Immun, 64, 1614, 10.1128/IAI.64.5.1614-1620.1996 Yang, 1996, Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis, J Nutr, 226, 1072, 10.1093/jn/126.suppl_4.1072S Kalayoglu, 1998, Induction of macrophage foam cell formation by Chlamydia pneumoniae, J Infect Dis, 177, 725, 10.1086/514241 Fryer, 1997, Chlamydia species infect human vascular endothelial cells and induce pro-coagulant activity, J Investig Med, 45, 168 Kol, 1998, Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression, Circulation, 98, 300, 10.1161/01.CIR.98.4.300 Kol, 1999, Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages, Clin Invest, 103, 571, 10.1172/JCI5310 Huang, 1996, In hipercolesterolemia, lower peripheral monocyte count is unique among the major predictors of atherosclerosis, Arterioscler Thromb Vasc Biol, 16, 256, 10.1161/01.ATV.16.2.256